SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stavreus Evers A) "

Sökning: WFRF:(Stavreus Evers A)

  • Resultat 1-10 av 80
  • [1]234567...8Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Murto, T., et al. (författare)
  • Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility
  • 2014
  • Ingår i: ; 28:6, s. 766-772
  • Tidskriftsartikel (refereegranskat)abstract
    • Folic acid supplements are commonly used by infertile women and lead to a positive folate status. However, the effect of folic acid supplements on pregnancy outcome in women with unexplained infertility has not been well investigated. This study evaluated folic acid supplement use and folate status in women with unexplained infertility in relation to pregnancy outcome. In addition, use of folic acid supplements and folate status were compared between women with unexplained infertility and fertile, nonpregnant control women. Women with unexplained infertility used significantly more folic acid supplements and had higher median total folic acid intake from supplements compared with fertile control women (both P < 0.001). Women with unexplained infertility also had significantly higher median plasma folate and lower median plasma homocysteine concentrations than fertile women (both P < 0.001), but folic acid supplementation or folate status were not related to pregnancy outcome in women with unexplained infertility. In conclusion, folic acid supplementation or good folate status did not have a positive effect on pregnancy outcome following infertility treatment in women with unexplained infertility.
  •  
2.
  • Bischof, P, et al. (författare)
  • Implantation of the human embryo: research lines and models. From the implantation research network 'Fruitful'.
  • 2006
  • Ingår i: Gynecologic and obstetric investigation. - : Karger. - 0378-7346 .- 1423-002X. ; 62:4, s. 206-16
  • Tidskriftsartikel (refereegranskat)abstract
    • Infertility is an increasing problem all over the world, and it has been estimated that 10-15% of couples in fertile age have fertility problems. Likewise induced unsafe abortion is a serious threat to women's health. Despite advances made in assisted reproduction techniques, little progress has been made in increasing the success rate during fertility treatment. This document describes a wide range of projects carried out to increase the understanding in the field of embryo implantation research. The 'Fruitful' research network was created to encourage collaborations within the consortium and to describe our different research potentials to granting agencies or private sponsors.
  •  
3.
  • Altmäe, Signe, et al. (författare)
  • Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility
  • 2010
  • Ingår i: Molecular human reproduction. - 1360-9947 .- 1460-2407. ; 16:3, s. 178-187
  • Tidskriftsartikel (refereegranskat)abstract
    • Successful embryo implantation depends on the quality of the embryo, as well as on the receptivity of the endometrium. The aim of this study was to investigate the endometrial gene expression profile in women with unexplained infertility in comparison with fertile controls at the time of embryo implantation in order to find potential predictive markers of uterine receptivity and to identify the molecular mechanisms of infertility. High-density oligonucleotide gene arrays, comprising 44 000 gene targets, were used to define the endometrial gene expression profile in infertile (n = 4) and fertile (n = 5) women during the mid-secretory phase (day LH +7). Microarray results were validated using real-time PCR. Analyses of expression data were carried out using non-parametric methods. Hierarchical clustering and principal component analysis showed a clear distinction in endometrial gene expression between infertile and fertile women. In total we identified 145 significantly (>3-fold change) up-regulated and 115 down-regulated genes in infertile women versus controls. Via Database for Annotation, Visualization and Integrated Discovery functional analysis we detected a substantial number of dysregulated genes in the endometria of infertile women, involved in cellular localization (21.1%) and transport (18.8%) and transporter activity (13.1%) and with major localization in extracellular regions (19.2%). Ingenuity Pathways Analysis of the gene list showed dysregulation of gene pathways involved in leukocyte extravasation signalling, lipid metabolism and detoxification in the endometria of infertile women. In conclusion, endometrial gene expression in women with unexplained infertility at the time of embryo implantation is markedly different from that in fertile women. These results provide new information on genes and pathways that may have functional significance as regards to endometrial receptivity and subsequent embryo implantation.
  •  
4.
  • Laanpere, Margit, et al. (författare)
  • Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability
  • 2010
  • Ingår i: Nutrition reviews. - 0029-6643 .- 1753-4887. ; 68:2, s. 99-113
  • Tidskriftsartikel (refereegranskat)abstract
    • This review summarizes current knowledge of the effect of folate-mediated one-carbon metabolism and related genetic variants on female fertility and pregnancy viability. Insufficient folate status disrupts DNA methylation and integrity and increases blood homocysteine levels. Elevated levels of follicular fluid homocysteine correlate with oocyte immaturity and poor early embryo quality, while methylenetetrahydrofolate reductase (MTHFR) gene variants are associated with lower ovarian reserves, diminished response to follicular stimulation, and reduced chance of live birth after in vitro fertilization. Embryos carrying multiple MTHFR variants appear to have a selective disadvantage; however, the heterozygousMTHFR 677CT genotype in the mother and fetus provides the greatest chance for a viable pregnancy and live birth, possibly due to a favorable balance in folate cofactor distribution between methyl donor and nucleotide synthesis. The results of previous studies clearly emphasize that imbalances in folate metabolism and related gene variants may impair female fecundity as well as compromise implantation and the chance of a live birth.
  •  
5.
  • Altmäe, Signe, et al. (författare)
  • Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome : a preliminary report
  • 2009
  • Ingår i: Reproductive Biomedicine Online. - 1472-6483 .- 1472-6491. ; 18:5, s. 651-657
  • Tidskriftsartikel (refereegranskat)abstract
    • Progress has been made towards ascertaining the genetic predictors of ovarian stimulation in IVF. Aromatase cytochrome P450, encoded by the CYP19A1 gene, catalyses a key step in ovarian oestrogen biosynthesis. Hence, the aromatase gene is an attractive candidate for genetic studies. This study aimed to examine the genetic influences of CYP19A1 TCT trinucleotide insertion/deletion (Ins/Del) and (TTTA)(n) microsatellite intronic polymorphisms on ovarian stimulation outcome and aetiology of female infertility. IVF patients (n = 152) underwent ovarian stimulation according to recombinant FSH and gonadotrophin releasing hormone antagonist protocol. Del/Del homozygous patients with shorter TTTA repeats exhibited decreased ovarian FSH sensitivity in ovarian stimulation, which may reflect variations in aromatase gene expression during early antral follicle development. Accordingly, this study demonstrates correlations between Del allele and shorter (TTTA)(n) repeat sizes with smaller ovaries (r = -0.70, P = 0.047) and fewer antral follicles (r = 0.21, P = 0.018) on days 3-5 of spontaneous menstrual cycle, respectively. Furthermore, Del variation linked with low-repeat-number (TTTA)(n) alleles are involved in enhanced genetic susceptibility to unexplained infertility (adjusted OR = 4.33, P = 0.039) and endometriosis (r = -0.88, P = 0.026), which corroborates evidence on the overlapping patient profiles of ovarian dysfunction in both types of female infertility.
  •  
6.
  • Hambiliki, F., et al. (författare)
  • Glycoprotein 130 promotes human blastocyst development in vitro
  • 2013
  • Ingår i: Fertility and Sterility. - 0015-0282 .- 1556-5653. ; 99:6, s. 1592-U444
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To investigate the efficacy of leukemia inhibitory factor (LIF) and/or glycoprotein 130 Design: Laboratory study. Setting: University hospital-based IVF clinic. Patient(s): A total of 164 frozen embryos that survived thawing were cultured in media supplemented Intervention(s): Morphological development was evaluated by light microscopy. Protein expression Main Outcome Measure(s): Embryo development and protein content. Result(s): Addition of gp130 to culture media improved blastocyst formation (73% vs. 43%). Addition of Conclusion(s): Glycoprotein 130, but not LIF, seems to be beneficial for preimplantation embryo
  •  
7.
  • Kunovac Kallak, T., et al. (författare)
  • Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients
  • 2012
  • Ingår i: Climacteric. - London, United Kingdom : Informa Healthcare. - 1369-7137 .- 1473-0804. ; 15:5, s. 473-480
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Vaginal estradiol is considered contraindicated in aromatase inhibitor (AI)-treated patients because of the risk of elevated estrogen levels. This leaves limited treatment options for patients experiencing gynecological symptoms. However, in clinical practice, no precise estimation has been performed of circulating estrogens and aromatase index in postmenopausal breast cancer patients on long-lasting AI or tamoxifen treatment.Methods: Steroid hormones were measured using liquid chromatography tandem mass spectrometry (LC-MS/MS) and extraction radioimmunoassay (RIA). Postmenopausal AI-treated patients (n =33) were compared with tamoxifen-treated patients (n =34) and controls without vaginal treatment (n =56), with vaginal estradiol (n =25), or with estriol (n =11) treatment.Results: By use of LC-MS/MS, median (range) estradiol plasma concentrations were 16.7 (2.4-162.6), 31.0 (13.4-77.1), 27.2 (7.8-115.8) and 33.3 (20.3-340.1) pmol/l in AI-treated breast cancer patients, tamoxifen-treated breast cancer patients, postmenopausal controls and postmenopausal controls on vaginal estradiol, respectively. The AI-treated group and subgroups had significantly lower estradiol and estrone concentrations than all other groups (p <0.05). There was extensive interindividual variation in estradiol concentration within the AI-treated group, measured using both LC-MS/MS (2.3-182.0 pmol/l) and extraction RIA (2.4-162.6 pmol/l). The AI-treated group had lower aromatase index compared to all other groups (p <0.05-0.001).Conclusion: Circulating estrogen levels may have been underestimated in previous longitudinal studies of AI-treated breast cancer patients. Additional studies are required to further evaluate the role of circulating estrogens in breast cancer patients suffering from gynecological symptoms.
  •  
8.
  • Murto, Tiina, et al. (författare)
  • Folic acid supplementation and methylenetetrahydrofolate reductase (MTHFR) gene variations in relation to in vitro fertilization pregnancy outcome
  • 2015
  • Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - 0001-6349 .- 1600-0412. ; 94:1, s. 65-71
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To study folic acid intake, folate status and pregnancy outcome after infertility treatment in women with different infertility diagnoses in relation to methylenetetrahydrofolate reductase (MTHFR) 677C>T, 1298A>C and 1793G>A polymorphisms. Also the use of folic acid supplements, folate status and the frequency of different gene variations were studied in women undergoing infertility treatment and fertile women.Design: Observational study.Setting: University hospital.Population: Women undergoing infertility treatment and healthy, fertile, non-pregnant women.Methods: A questionnaire was used to assess general background data and use of dietary supplements. Blood samples were taken to determine plasma folate and homocysteine levels, and for genomic DNA extraction. A comparison of four studies was performed to assess pregnancy outcome in relation to MTHFR 677 TT vs. CC, and 1298 CC vs. AA polymorphisms.Main outcome measures: Folic acid supplement intake, and plasma folate, homocysteine and genomic assays.Results: Women in the infertility group used significantly more folic acid supplements and had better folate status than fertile women, but pregnancy outcome after fertility treatment was not dependent on folic acid intake, folate status or MTHFR gene variations.Conclusion: High folic acid intakes and MTHFR gene variations seem not to be associated with helping women to achieve pregnancy during or after fertility treatment.
  •  
9.
  • Altmae, Signe, et al. (författare)
  • Variations in folate pathway genes are associated with unexplained female infertility
  • 2010
  • Ingår i: Fertility and Sterility. - 0015-0282 .- 1556-5653. ; 94:1, s. 130-137
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To investigate associations between folate-metabolizing gene variations, folate status, and unexplained female infertility. Design: An association study. Setting: Hospital-based IVF unit and university-affiliated reproductive research laboratories. Patient(s): Seventy-one female patients with unexplained infertility. Intervention(s): Blood samples for polymorphism genotyping and homocysteine, vitamin B12, and folate measurements. Main Outcome Measure(s): Allele and genotype frequencies of the following polymorphisms: 5,10-methylenetetra-hydrofolate reductase (MTHFR) 677C/T, 1298A/C, and 1793G/A, folate receptor 1 (FOLR1) 1314G/A, 1816delC, 1841G/A, and 1928C/T, transcobalamin II (TCN2) 776C/G, cystathionase (CTH) 1208G/T and solute carrier family 19, member 1 (SLC19A1) 80G/A, and concentrations of plasma homocysteine, vitamin B12, and serum folate. Result(s): MTHFR genotypes 677CT and 1793GA, as well as 1793 allele A were significantly more frequent among controls than in patients. The common MTHFR wild-type haplotype (677, 1298, 1793) CAG was less prevalent, whereas the rare haplotype CCA was more frequent in the general population than among infertility patients. The frequency of SLC19A1 80G/A genotypes differed significantly between controls and patients and the A allele was more common in the general population than in infertile women. Plasma homocysteine concentrations were influenced by CTH 1208G/T polymorphism among infertile women. Conclusion(s): Polymorphisms in folate pathway genes could be one reason for fertility complications in some women with unexplained infertility. (Fertil Steril (R) 2010;94:130-7. (C) 2010 by American Society for Reproductive Medicine.)
  •  
10.
  • Altmäe, Signe, 1978-, et al. (författare)
  • Genetic predictors of controlled ovarian hyperstimulation : where do we stand today?
  • 2011
  • Ingår i: Human Reproduction Update. - 1355-4786 .- 1460-2369. ; 17:6, s. 813-828
  • Forskningsöversikt (refereegranskat)abstract
    • BACKGROUNDNowadays, the use of IVF has improved the prospects of infertility treatment. The expected outcome of IVF depends greatly on the effectiveness of controlled ovarian hyperstimulation (COH), where exogenous gonadotrophins are used to induce folliculogenesis. The response to stimulation varies substantially among women and is difficult to predict. Several predictive markers of COH outcome have been proposed (e.g. maternal age and ovarian reserve), but the search for optimal predictors is ongoing. Pharmacogenetic studies demonstrate the effects of individual genetic variability on COH outcome and the potential for customizing therapy based on the patient's genome.METHODSMEDLINE, EMBASE, DARE, CINAHL and the Cochrane Library, and references from relevant articles were investigated up to February 2011 regarding any common genetic variation and COH/IVF outcome.RESULTSSeveral polymorphisms in genes involved in FSH signalling, estrogen biosynthesis, folliculogenesis, folate metabolism and other aspects influence the response to exogenous gonadotrophin administration, resulting in differences in COH and IVF outcomes. Nevertheless, the most studied polymorphism FSHR Asn680Ser is practically the only genetic marker, together with ESR1 PvuII T/C, that could be applied in clinical tests.CONCLUSIONSAlthough data are accumulating with evidence suggesting that the ovarian response to COH is mediated by various polymorphisms, the optimal biomarkers and the efficacy of the tests still remain to be evaluated.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 80
  • [1]234567...8Nästa
Typ av publikation
tidskriftsartikel (69)
konferensbidrag (9)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (69)
övrigt vetenskapligt (11)
Författare/redaktör
Stavreus-Evers, A (78)
Stavreus-Evers, Anne ... (34)
Hovatta, O (20)
Landgren, BM (20)
Salumets, A (19)
Altmae, S (18)
visa fler...
Altmäe, Signe (16)
Gemzell-Danielsson, ... (13)
Aghajanova, L (12)
Wanggren, K (12)
Landgren, Britt-Mari ... (11)
Salumets, Andres (11)
Stavreus-Evers, Anne ... (11)
Nilsson, Torbjörn K (8)
Eriksson, H (7)
Hovatta, Outi (7)
Wånggren, Kjell (7)
Zhang, P. (6)
Aghajanova, Lusine (6)
Bjuresten, K (6)
Skjoldebrand-Sparre, ... (6)
Yngve, A (6)
Bergquist, J. (5)
Mints, M (5)
Sundström Poromaa, I ... (5)
Akerud, H (5)
Simon, C (5)
Nilsson, TK (4)
Bjuresten, Kerstin (4)
Skjöldebrand-Sparre, ... (4)
Bremme, K (4)
Sahlin, L (4)
Yngve, Agneta, 1953- (4)
Lalitkumar, PG (4)
Horcajadas, J. A. (4)
Kallak, TK (4)
Kallak, Theodora Kun ... (4)
Bremme, Katarina (4)
Nilsson, K. (3)
Bergquist, Jonas (3)
Scott, JE (3)
Altmae, Signe (3)
Nielsen, S (3)
Skjoldebrand-Sparre, ... (3)
Peters, M (3)
Horcajadas, JA (3)
Esteban, Francisco J ... (3)
Horcajadas, Jose A. (3)
Ruiz, Jonatan R. (3)
Laanpere, M (3)
visa färre...
Lärosäte
Karolinska Institutet (65)
Uppsala universitet (41)
Örebro universitet (6)
Umeå universitet (5)
Göteborgs universitet (2)
Lunds universitet (2)
visa fler...
Kungliga Tekniska Högskolan (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (80)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (23)
Naturvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy